Cargando…
Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707616/ https://www.ncbi.nlm.nih.gov/pubmed/31523119 |
_version_ | 1783445887700172800 |
---|---|
author | Call, Mindy Elzarka, Mohamed Kunesh, Mary Hura, Nanki Birk, David E. Kao, Winston W. |
author_facet | Call, Mindy Elzarka, Mohamed Kunesh, Mary Hura, Nanki Birk, David E. Kao, Winston W. |
author_sort | Call, Mindy |
collection | PubMed |
description | PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen fibrils that allows for transparency may be disrupted due to genetic mutations and injuries. The purpose of this study is to examine the therapeutic efficacy of human umbilical cord mesenchymal stem/stromal cells (UMSCs) in treating congenital and acquired corneal opacity associated with the loss of collagen V. METHODS: Experimental mice, i.e., wild-type, Col5a1(f/f) and Kera-Cre/Col5a1(f/f) (Col5a1(∆st/∆st), collagen V null in the corneal stroma) mice in a C57BL/6J genetic background, were subjected to a lamellar keratectomy, and treated with or without UMSC (10(4) cells/cornea) transplantation via an intrastromal injection or a fibrin plug. In vivo Heidelberg retinal tomograph (HRT II) confocal microscopy, second harmonic generated (SHG) confocal microscopy, histology, and immunofluorescence microscopy were used to assess the corneal transparency of the regenerated corneas. RESULTS: Col5a1(∆st/∆st) mice display a cloudy cornea phenotype that is ameliorated following intrastromal transplantation of UMSCs. Loss of collagen V in Col5a1(∆st/∆st) corneas augments the formation of cornea scarring following the keratectomy. UMSC transplantation with a fibrin plug improves the healing of injured corneas and regeneration of transparent corneas, as determined with in vivo HRT II confocal microscopy. Second harmonic confocal microscopy revealed the improved collagen fibril lamellar architecture in the UMSC-transplanted cornea in comparison to the control keratectomized corneas. CONCLUSIONS: UMSC transplantation was successful in recovering some corneal transparency in injured corneas of wild-type, Col5a1(f/f) and Col5a1(∆st/∆st) mice. The production of collagen V by transplanted UMSCs may account for the regeneration of corneal transparency, as exemplified by better collagen fiber organization, as revealed with SHG signals. |
format | Online Article Text |
id | pubmed-6707616 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Molecular Vision |
record_format | MEDLINE/PubMed |
spelling | pubmed-67076162019-09-13 Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity Call, Mindy Elzarka, Mohamed Kunesh, Mary Hura, Nanki Birk, David E. Kao, Winston W. Mol Vis Research Article PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen fibrils that allows for transparency may be disrupted due to genetic mutations and injuries. The purpose of this study is to examine the therapeutic efficacy of human umbilical cord mesenchymal stem/stromal cells (UMSCs) in treating congenital and acquired corneal opacity associated with the loss of collagen V. METHODS: Experimental mice, i.e., wild-type, Col5a1(f/f) and Kera-Cre/Col5a1(f/f) (Col5a1(∆st/∆st), collagen V null in the corneal stroma) mice in a C57BL/6J genetic background, were subjected to a lamellar keratectomy, and treated with or without UMSC (10(4) cells/cornea) transplantation via an intrastromal injection or a fibrin plug. In vivo Heidelberg retinal tomograph (HRT II) confocal microscopy, second harmonic generated (SHG) confocal microscopy, histology, and immunofluorescence microscopy were used to assess the corneal transparency of the regenerated corneas. RESULTS: Col5a1(∆st/∆st) mice display a cloudy cornea phenotype that is ameliorated following intrastromal transplantation of UMSCs. Loss of collagen V in Col5a1(∆st/∆st) corneas augments the formation of cornea scarring following the keratectomy. UMSC transplantation with a fibrin plug improves the healing of injured corneas and regeneration of transparent corneas, as determined with in vivo HRT II confocal microscopy. Second harmonic confocal microscopy revealed the improved collagen fibril lamellar architecture in the UMSC-transplanted cornea in comparison to the control keratectomized corneas. CONCLUSIONS: UMSC transplantation was successful in recovering some corneal transparency in injured corneas of wild-type, Col5a1(f/f) and Col5a1(∆st/∆st) mice. The production of collagen V by transplanted UMSCs may account for the regeneration of corneal transparency, as exemplified by better collagen fiber organization, as revealed with SHG signals. Molecular Vision 2019-08-07 /pmc/articles/PMC6707616/ /pubmed/31523119 Text en Copyright © 2019 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed. |
spellingShingle | Research Article Call, Mindy Elzarka, Mohamed Kunesh, Mary Hura, Nanki Birk, David E. Kao, Winston W. Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title | Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title_full | Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title_fullStr | Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title_full_unstemmed | Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title_short | Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
title_sort | therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707616/ https://www.ncbi.nlm.nih.gov/pubmed/31523119 |
work_keys_str_mv | AT callmindy therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity AT elzarkamohamed therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity AT kuneshmary therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity AT hurananki therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity AT birkdavide therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity AT kaowinstonw therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity |